Search
Contact
Score Calculators
Research
Research by funder
EF CLIF
European Union
Other funders
Private companies
Research by topic
Liver pathophysiology
Clinical course of chronic liver disease
Biomarker discovery
Therapeutic innovation
Publications
Flagship projects
Observational studies
ACLARA
CANONIC
CHANCE
COBALT
PREDICT
Translational research
DISCOVERY
Grifols Chair Program
People
Research infrastructure
News & Events
About us
Our history
Our strategy
Our organization
Governance
Executive Team
Committees
Working Groups
Our network
EASL-CLIF Consortium
European Network for Translational Research
Global Projects
Our partners
Annual Reports
Contact
Research
Research by funder
EF CLIF
European Union
Other funders
Private companies
Research by topic
Liver pathophysiology
Clinical course of chronic liver disease
Biomarker discovery
Therapeutic innovation
Publications
Flagship projects
Observational studies
ACLARA
CANONIC
CHANCE
COBALT
PREDICT
Translational research
DISCOVERY
Grifols Chair Program
People
Research infrastructure
News & Events
About us
Our history
Our strategy
Our organization
Governance
Executive Team
Committees
Working Groups
Our network
EASL-CLIF Consortium
European Network for Translational Research
Global Projects
Our partners
Annual Reports
Contact
Other funders
Ongoing research
Past research
A possible role for FXR polymorphisms in the etiopathogenesis of acute decompensation of cirrhosis and ACLF: An observational study within CANONIC and PREDICT
Biomarkers of renal tubular damage in predicting response to terlipressin and albumin in patients with hepatorenal syndrome
Glycomics-based biomarkers for diagnosis and prognosis in ACLF
Molecular markers to predict chronic liver failure and to explore its mechanistic pathways in decompensated cirrhosis
Related News
View all news
